Downsizing sweeps drugmakers

Published: 2009-01-30 06:59:00

Updated: 2009-01-30 06:59:00

A number of pharmaceutical firms are implementing massive restructuring measures as they look to respond to collapsed demand in the midst of the accelerating business slump.

With pharmaceutical firms cutting production, excipient manufacturers are having trouble.

“The problem now is that de...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK